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Abstract
Background:  Cystic echinococcosis (CE) is caused by the larva of tapeworm Echinococcus
granulosus. Dogs and other canids are the primary definitive hosts for this parasite. CE may develop
after accidental ingestion of tapeworm eggs, excreted with the feces of these animals. In the
intestine, the larvae released from the eggs are nested in the liver, lungs or other organs of livestock
as intermediate hosts and humans as aberrant hosts. The aim of this study was to examine
serologically whether some of the patients in Slovenia, suspected of CE by imaging findings in the
liver or lungs had been infected with the larva of Echinococcus granulosus.
Methods: Between January 1, 2002 and the end of December 2006, 1323 patients suspected of
having echinococcosis were screened serologically by indirect haemagglutination assay (IHA). For
confirmation and differentiation of Echinococcus spp. infection, the sera of IHA-positive patients
were then retested by western blot (WB).
Results: Out of 127 IHA-positive sera, 34 sera were confirmed by WB and considered specific for
CE. Of 34 sera of CE-positive patients sera, 32 corresponded to the characteristic imaging findings
of a liver cysts and 2 to those of lung cysts. The mean age of CE-positive patients was 58.3 years.
No significant differences were found between the CE-positive patients in regard to their sex.
Conclusion: In the study, it was found out that CE was mostly spread in the same area of Slovenia
as in the past, but its prevalence decreased from 4.8 per 105 inhabitants in the period 1956–1968
to 1.7 per 105 inhabitants in the period 2002–2006. In spite of the decreased prevalence of CE in
the last years, it is suggested that clinicians and public health authorities, especially in the eastern
parts of Slovenia where the most CE patients come from, should pay greater attention to this
disease in the future.
Background
Human cystic echinococcosis (CE) is caused mainly by
the larva of tapeworm Echinococcus granulosus. E. granulo-
sus occurs worldwide. It is 2–7 mm long and is harboured
in the intestine of definitive hosts, typically dogs and
other canids which are infected by the ingestion of offal
containing larval stage of E. granulosus. The tapeworm eggs
are excreted with the faeces of these animals. Following
accidental ingestion of these eggs, CE in larval stage may
develop in ungulates and sometimes in humans as inter-
mediate hosts, usually in the liver or lung [1]. The aim of
this study was to examine serologically whether the Slov-
enian patients suspected of having cystic echinococcosis
had been infected by the larvae of E. granulosus.
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Methods
Between 1 January 2002 and the end of December 2006,
1323 patients suspected of having CE (because their ultra-
sound or computerised tomography scans showed round
or oval lesions of different size in the liver or lung) were
serologically examined for this disease at the Department
of Parasitology, Institute of Microbiology and Immunol-
ogy, Medical Faculty of Ljubljana. The sera were obtained
from the patients of both genders and different ages, and
from different parts of Slovenia. The sera were screened by
an indirect haemagglutination assay (IHA) (Cellognost-
Echinococcosis, Dade Behring, Marburg, Germany).
IHA-low positive titres of 1:32 to 1:128 or higher could
only be accepted as positive for echinococcosis if con-
firmed in conjunction with a second serological method,
e. g. immunofluorescent test, ELISA, western blot (WB).
For confirmation and differentiation between CE and
alveolar echinococcosis (AE) caused by Echinococcus multi-
locularis, all IHA sera with low, mid-range, and high titres
were retested by WB IgG (LDBIO Diagnostics, Lyon,
France). According to the manufacturer's interpretation
data and test evaluation by Liance et al., 2000, immunob-
lot patterns P1 with only a 7 kDa band, and P2 with a
band at 7 kDa and at least a diffuse band at 16–18 kDa are
specific for CE. Pattern P3 with at least one band at 26–28
kDa plus two sharp bands at 16 and 18 kDa is the most
specific pattern for AE. Pattern P4 which includes only
one band of 26 to 28 kDa is also c. 88% specific for AE.
Pattern P5 with the bands at 7 kDa and 26–28 kDa and
without additional intermediate bands cannot be used to
discriminate between the two species [2]. Because of pos-
sible cross-reactivity with neurocysticercosis, E. granulosus-
positive sera were retested using an immunoblot assay
Cysticercosis WB IgG (LDBIO Diagnostics).
The research has been performed with the approval of the
National Medical Ethics Committee of the Republic of
Slovenia. Concerning the statements of the NMEC, in true
non-interventional, purely observational studies, classical
informed consent is not required, similarly to the situa-
tion with epidemiological studies, which do not involve
any intervention on or interaction with patients and
where the right to confidentiality/private life is not inter-
fered with.
Results
In 127 of 1323 sera from the patients with suspected echi-
nococcosis, antibodies to Echinococcus spp. with low to
high titres were detected by IHA. Out of IHA-positive sera
that were not confirmed by WB, 74 sera were positive in
the low titres 1:32–1:128, 4 were positive in the titre
1:256, and one in the titre 1:512. Of 127 IHA-positive
sera, only 48 sera were positive for echinococcosis by WB.
Eight sera with pattern P4 were already confirmed in our
previous study to be positive for alveolar echinococcosis.
Six sera with pattern P5 with no possibility to discriminate
between two species were not studied further [3]. Of 48
sera, 32 sera of patients with cysts in the liver (3 sera were
IHA-positive in the titre 1:64, 4 in the titre 1:128, 11 in the
titre 1:256, 6 in the titre 1:512, 2 in the titre 1:1024, 1 in
the titre 1:2048, 2 in the titre 1:4096 and 3 sera in the titre
1:8192) and two sera of patients with lung echinococcosis
(1 serum was positive in the IHA titre 1:256 and other in
the titre 1:512) appeared to be positive for CE caused by
Echinococcus granulosus, as the antibodies in these sera
bound specifically to antigen at 7 kDa only or to 7 kDa
and diffuse band at 16–18 kDa. Twenty four sera were
from women, while 10 sera were from men. The mean age
of detected CE positive patients was 58.3 years. CE-posi-
tive serological results of the patients corresponded to the
imaging findings (univesicular, round or oval cysts with
well defined wall contours and the size ranging between 1
and 10 cm) in their liver and lungs. All CE positive sera
tested by the immunoblot assay were negative for cysticer-
cosis.
Discussion
It is known that the initial phase of primary Echinococcus
infection is always asymptomatic. Small cysts not induc-
ing major disease may remain asymptomatic for many
years, if not permanently. The incubation period of CE is
unclear, but probably lasts for many months to years. The
infection may become symptomatic if the cysts either rup-
ture or exert a mass-effect. The cystic larva develops
mainly in the liver (70%), also in the lungs (20%) and
10% of cysts can occur almost anywhere in the body [4-6].
In our study, CE was detected more frequently in the liver
than in the lungs, but it is impossible to compare these
results because more examined sera were obtained from
the patients with visceral than with lungs disorders. From
the data in the literature, CE may occur in the subjects
younger than 1 year to those older than 75 years [1]. The
age of our CE-positive patients ranged from 24 to 86 years,
with the mean age of 58.3 years. No significant differences
were found between the CE-positive patients in regard to
their sex.
E. granulosus has a worldwide geographical distribution. It
is found on all continents, with the highest prevalence in
parts of the Russian Federation and adjacent independent
states, China, north and east Africa, Australia, and South
America. In Europe, it is present in every country or region
(the annual incidence of hospital cases of human CE vary
between <1 and >8 per 105 population) with the excep-
tion of Ireland, Iceland and Denmark. It is most intensely
endemic in parts of Spain, southern Italy and Sardinia.
Reports from several countries also provide documented
evidence of an increase in the CE incidence in recent years.
For example in Bulgaria the annual incidence of CE inBMC Infectious Diseases 2008, 8:63 http://www.biomedcentral.com/1471-2334/8/63
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children increased from 0.7 per 105 in 1971–1982 to 5.4
in 1995. Also in the northern part of Italy, where this dis-
ease plays a minor role, the average yearly human CE-inci-
dence during 2003–2005 was between 9.4 and 5.6 per 105
inhabitants [4,5,7,8]. In 1956 to 1968, the prevalence of
CE in the total population of Slovenia, was 4.8 per 105
inhabitants [9]. In this study, it was found out that CE was
mostly spread in the same area, i.e. eastern part of the
country, as in the past years, but its prevalence for the five-
year period was lower, just about 1.7 per 105 inhabitants,
with the mean annual incidence of 0.34 cases per 105
inhabitants (Figure 1).
Most forms of human CE are transmitted in domestic life-
cycles involving dogs and livestock. The most known is
the sheep-dog cycle. In the last years, it has been recog-
nised by genetic characterisation that, in the genus of
Echinococcus, there are distinct species and strains (e.g.
sheep, pig, cattle, cervid, camel strain) based on morphol-
ogy, host specificity and molecular characteristics [10,11].
In the 1970's, Brglez estimated that the pig (its breeding is
also nowadays the most wide-spread in the eastern parts
of the country) was the most important intermediate host
in epidemiological and epizootiological conditions of CE
in Slovenia [9]. Because it is impossible to allocate the
detected CE-positive cases to any of the above mentioned
forms by serological methods used in our study, we can
only conclude that our patients have been infected by one
of species/strains of Echinococcus granulosus complex. It is
suggested that the decrease of CE reported in this study is
probably due to the controlled and reduced slaughtering
by the breeders themselves, better general and sanitary
attitude of livestock breeders, especially pig breeders, pro-
vision of safe drinking water, and control and
anthelmintic treatment of dog population.
Conclusion
The results of this study suggest that CE is still a public
health problem in Slovenia, predominantly in the eastern
areas of the country; therefore, clinicians and health
authorities should pay grater attention to CE and should
make additional efforts to decrease or even eliminate this
disease in the future.
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Regions in Slovenia where the patients' sera tested for CE came from Figure 1
Regions in Slovenia where the patients' sera tested for CE came from. From the yellow coloured area, the sera of 
483 patients were tested for CE of which 2 (0.4%) sera were confirmed positive (*) for CE, and the sera of 481 (99.6%) 
patients were CE negative. From the red (eastern) coloured area, the sera of 840 patients were tested for CE of which 32 (4%) 
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